BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32009177)

  • 1. Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer.
    Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Gocho T; Fukushima Y; Hori M; Miura K; Takada Y; Nakata K; Sakata KI
    J Radiat Res; 2020 Mar; 61(2):265-274. PubMed ID: 32009177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
    Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
    Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: A single-center retrospective study.
    Zhang N; Tang Y; Guo X; Mao Z; Yang W; Cheng G
    Brachytherapy; 2020; 19(2):194-200. PubMed ID: 31791712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer.
    Murakami N; Kasamatsu T; Wakita A; Nakamura S; Okamoto H; Inaba K; Morota M; Ito Y; Sumi M; Itami J
    BMC Cancer; 2014 Jun; 14():447. PubMed ID: 24938757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography-based image-guided brachytherapy for cervical cancer: correlations between dose-volume parameters and clinical outcomes.
    Kusada T; Toita T; Ariga T; Maemoto H; Hashimoto S; Shiina H; Kakinohana Y; Heianna J; Nagai Y; Kudaka W; Aoki Y; Murayama S
    J Radiat Res; 2018 Jan; 59(1):67-76. PubMed ID: 29186565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
    Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Yang W; Wu X
    Med Phys; 2013 Dec; 40(12):121703. PubMed ID: 24320489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-volume histogram analysis of composite EQD2 dose distributions using the central shielding technique in cervical cancer radiotherapy.
    Tamaki T; Noda SE; Ohno T; Kumazaki Y; Kato S; Nakano T
    Brachytherapy; 2016; 15(5):598-606. PubMed ID: 27475482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer.
    Ohkubo Y; Ohno T; Noda SE; Kubo N; Nakagawa A; Kawahara M; Abe T; Kiyohara H; Wakatsuki M; Nakano T
    J Radiat Res; 2013 Nov; 54(6):1138-45. PubMed ID: 23732770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric feasibility of computed tomography-based image-guided brachytherapy in locally advanced cervical cancer: a Japanese prospective multi-institutional study.
    Otani Y; Ohno T; Ando K; Murata K; Kato S; Noda SE; Murofushi K; Ushijima H; Yoshida D; Okonogi N; Isohashi F; Wakatsuki M; Nakano T
    J Radiat Res; 2021 May; 62(3):502-510. PubMed ID: 33532828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotating-shield brachytherapy for cervical cancer.
    Yang W; Kim Y; Wu X; Song Q; Liu Y; Bhatia SK; Sun W; Flynn RT
    Phys Med Biol; 2013 Jun; 58(11):3931-41. PubMed ID: 23680601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-volume parameters and local tumor control in cervical cancer treated with central-shielding external-beam radiotherapy and CT-based image-guided brachytherapy.
    Okazaki S; Murata K; Noda SE; Kumazaki Y; Hirai R; Igari M; Abe T; Komatsu S; Nakano T; Kato S
    J Radiat Res; 2019 Jul; 60(4):490-500. PubMed ID: 31111896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of conventional HDR intracavitary brachytherapy combined with complementary applicator-guided intensity modulated radiotherapy boost in patients with bulky cervical tumour.
    Lu S; Wang S; Kim RY; Zhang J; Wang X; Wang W; Zhu G; Zhou J; Tan Y; Tan M; Li M; Yin G; Li J; Feng M; Lang J
    BJOG; 2023 Jan; 130(2):231-237. PubMed ID: 36330947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.
    Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
    Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal separation using hydroxypropyl methylcellulose in intracavitary brachytherapy of cervical cancer: an innovative approach.
    Basu S; Manir KS; Basu A; Ghosh K
    J Contemp Brachytherapy; 2016 Oct; 8(5):399-403. PubMed ID: 27895681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
    Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
    Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
    Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients.
    Kusada T; Toita T; Ariga T; Kudaka W; Maemoto H; Makino W; Ishikawa K; Heianna J; Nagai Y; Aoki Y; Murayama S
    Int J Clin Oncol; 2020 Nov; 25(11):1977-1984. PubMed ID: 32852648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.